Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 47 results

research Weekly Treatment with SAMiRNA Targeting the Androgen Receptor Ameliorates Androgenetic Alopecia

3 citations, January 2022 in “Scientific Reports”

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

research Author Correction: Weekly Treatment with SAMiRNA Targeting the Androgen Receptor Ameliorates Androgenetic Alopecia

April 2022 in “Scientific Reports”

research Current Landscape and Emerging Therapies in Hair Loss Treatment for Androgenetic Alopecia

November 2024 in “EMJ Dermatology”

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

research The State-of-the-Art in the Management of Androgenetic Alopecia: A Review of New Therapies and Treatment Algorithms

1 citations, July 2022 in “JEADV Clinical Practice”

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

research Interaction Between Dermal Papilla Cells and Follicular Epithelial Cells In Vitro: Effect of Androgen

48 citations, April 1995 in “PubMed”

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

View more "samirna" in research →

Community Join

5 / 7 results

community Hold up... CosmeRNA/SAMiRNA is actually coming real soon?

in Technology 31 upvotes 1 year ago

A user discovered CosmeRNA, a new hair loss treatment with clinical research backing, set to release soon. The conversation revolves around its potential effectiveness, cost, and how it compares to existing treatments like Minoxidil and Finasteride, with some users expressing hope for a side-effect-free option.

community Kintor Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China.

in Research/Science 133 upvotes 1 year ago

Kintor Pharma has started a Phase II trial in China for GT20029, a potential new treatment for hair loss. Participants are discussing the significance, potential release dates, and comparing it to other treatments and technologies like stem cell hair transplants and SAMIRNA.

community Concerns about CosmeRNA safety mechanisms

in Treatment 3 upvotes 1 year ago

Concerns about CosmeRNA safety mechanisms and potential side effects. Discussion includes comparisons to Fluridil and questions about nanoparticle specificity and siRNA stability.

community Since there is so much hype for cosmeRNA and HMI-115...

in Chat 47 upvotes 1 year ago

Exploring different treatments for hair loss, such as cosmeRNA and HMI-115 which are small interference messenger RNA that inhibits the DHT receptor and an antibody that binds to the prolactin (PRL) receptor respectively; and researching mechanism and environment of hyperresponders.

community Anyone excited for CosmeRNA coming this month?

in Product 171 upvotes 1 year ago

CosmeRNA, a new hair loss treatment, is expected to release soon and may become part of the "big three" treatments alongside finasteride and minoxidil. It works differently from finasteride by targeting androgen receptors in hair follicles, potentially offering fewer side effects.

View more "samirna" in community →